Perspective Therapeutics, Inc. Common Stock Shares Outstanding

• Perspective Therapeutics, Inc. showed an increase of +5.2% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
• XBRL data for this metric is available from 2012 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2012 to 2025), Perspective Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 140.2%.
• Historical annual values: Fiscal year 2025: 74.34 million shares | Fiscal year 2024: 70.67 million shares | Fiscal year 2023: 28.18 million shares | Fiscal year 2022: 142.11 million shares | Fiscal year 2022: 142.04 million shares | Fiscal year 2021: 141.92 million shares | Fiscal year 2020: 68.90 million shares | Fiscal year 2019: 67.39 million shares | Fiscal year 2018: 56.33 million shares | Fiscal year 2017: 55.02 million shares | Fiscal year 2016: 55.01 million shares | Fiscal year 2015: 54.97 million shares | Fiscal year 2014: 38.42 million shares | Fiscal year 2014: 54.70 million shares | Fiscal year 2014: 41.54 million shares | Fiscal year 2013: 38.42 million shares | Fiscal year 2013: 34.62 million shares | Fiscal year 2012: 30.95 million shares.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026